SCHEMBL4028810

SCHEMBL4028810

COc1cccc(-c2[nH]c(C3CCN(OC(=O)OC(C)(C)C)CC3)nc2-c2ccncc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK13 O15264 3/20 0.43
RAF1 P04049 3/20 0.43
MAPK12 P53778 3/20 0.43
MAPK11 Q15759 3/20 0.43
MAPK14 Q16539 3/20 0.43
CDC7 O00311 1/20 0.42
KIT P10721 6/20 0.41
ALOX5 P09917 1/20 0.41
CSNK1A1 P48729 1/20 0.39
CSNK1D P48730 1/20 0.39
RPS6KA3 P51812 1/20 0.39
BRAF P15056 3/20 0.39
MAPK9 P45984 2/20 0.38
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
ADORA2B P29275 1/20 0.37
ADORA1 P30542 1/20 0.37
PDE10A Q9Y233 1/20 0.37
ROCK2 O75116 1/20 0.37
PRKG1 Q13976 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4025591 0.88 HTT (0.47) MAPK13RAF1MAPK12MAPK11MAPK14
SCHEMBL4033802 0.84 CSNK1A1 (0.58) MAPK13RAF1MAPK12MAPK11MAPK14
SCHEMBL8576094 0.83 MAPK14 (0.51) MAPK13RAF1MAPK12MAPK11MAPK14
SCHEMBL13810545 0.82 MAPK11 (0.53) MAPK13RAF1MAPK12MAPK11MAPK14
SCHEMBL8602866 0.80 USP30 (0.45) MAPK13RAF1MAPK12MAPK11MAPK14
SCHEMBL13810546 0.77 MAPK13 (0.46) MAPK13RAF1MAPK12MAPK11MAPK14
SCHEMBL4028673 0.74 MAPK14 (0.56) MAPK13RAF1MAPK12MAPK11MAPK14
SCHEMBL3099823 0.72 HTT (0.59) ALDH1A1
SCHEMBL27538196 0.72 MAPK14 (0.47) MAPK14CDC7ALOX5CSNK1A1CSNK1D
SCHEMBL4584849 0.71 CSNK1A1 (0.60) MAPK13RAF1MAPK12MAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0854870-B1 SUBSTITUTED IMIDAZOLES HAVING ANTI-CANCER AND CYTOKINE INHIBITORY ACTIVITY MERCK & CO INC (US) 2009-06-10 EP claimed